Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
59
CTRE Quote, Financials, Valuation and Earnings
Last price:
$40.04
Seasonality move
:
4.17%
Day range:
$39.61 - $40.32
52-week range:
$24.79 - $41.36
Dividend yield:
3.35%
P/E ratio:
25.77x
P/S ratio:
17.14x
P/B ratio:
2.21x
Volume:
1.4M
Avg. volume:
1.9M
1-year change:
56.32%
Market cap:
$8.9B
Revenue:
$476.6M
EPS (TTM):
$1.55
Analysts' Opinion
-
Consensus RatingCareTrust REIT, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $43.27, CareTrust REIT, Inc. has an estimated upside of 8.05% from its current price of $40.05.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $39.00 representing 100% downside risk from its current price of $40.05.
Fair Value
-
According to the consensus of 9 analysts, CareTrust REIT, Inc. has 8.05% upside to fair value with a price target of $43.27 per share.
CTRE vs. S&P 500
-
Over the past 5 trading days, CareTrust REIT, Inc. has underperformed the S&P 500 by -1.28% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
CareTrust REIT, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
CareTrust REIT, Inc. has grown year-over-year revenues for 14 quarters straight. In the most recent quarter CareTrust REIT, Inc. reported revenues of $135.1M.
Earnings Growth
-
CareTrust REIT, Inc. has grown year-over-year earnings for 10 quarters straight. In the most recent quarter CareTrust REIT, Inc. reported earnings per share of $0.50.
Enterprise value:
9.6B
EV / Invested capital:
--
Price / LTM sales:
17.14x
EV / EBIT:
31.00x
EV / Revenue:
20.24x
PEG ratio (5yr expected):
0.26x
EV / Free cash flow:
25.45x
Price / Operating cash flow:
21.55x
Enterprise value / EBITDA:
23.86x
Gross Profit (TTM):
$374.9M
Return On Assets:
7.19%
Net Income Margin (TTM):
67.05%
Return On Equity:
9.25%
Return On Invested Capital:
7.45%
Operating Margin:
64.1%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $217.8M | $296.3M | $476.6M | $87M | $135.1M | |
| Gross Profit | $157M | $225.9M | $374.9M | $68.2M | $106.9M | |
| Operating Income | $135.2M | $190.8M | $311.1M | $52.7M | $86.6M | |
| EBITDA | $186.4M | $247.6M | $404.2M | $68.2M | $113.9M | |
| Diluted EPS | $0.48 | $0.78 | $1.55 | $0.29 | $0.50 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $27.1M | $12.7M | $15.4M | $368.3M | $300.6M | |
| Total Assets | $1.6B | $1.6B | $2.1B | $3.4B | $5.1B | |
| Current Liabilities | $51.7M | $27.6M | -- | $54.4M | $74.8M | |
| Total Liabilities | $725.1M | $771.4M | $666.1M | $507.6M | $1.1B | |
| Total Equity | $915.8M | $849.4M | $1.4B | $2.9B | $4.1B | |
| Total Debt | $673.4M | $719.5M | $595.6M | $396.9M | $894.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $154.8M | $244.3M | $394M | $75.2M | $121M | |
| Cash From Investing | -$265.9M | -$1.5B | -$1.5B | -$667M | -$558.7M | |
| Cash From Financing | $392.4M | $1.2B | $1B | $428.5M | -$76.9M | |
| Free Cash Flow | $143.8M | $236.2M | $379M | $71.4M | $116M | |
CTRE
Sector
Market Cap
$8.9B
$938.7M
Price % of 52-Week High
96.83%
89.86%
Dividend Yield
3.35%
2.26%
Shareholder Yield
-10.83%
3.36%
1-Year Price Total Return
56.32%
--
Beta (5-Year)
0.752
0.634
Dividend yield:
3.35%
Annualized payout:
$1.34
Payout ratio:
67.34%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$39.94
200-day SMA
Buy
Level
$33.93
Bollinger Bands (100)
Buy
Level
34.86 - 38.08
Chaikin Money Flow
Buy
Level
6.2M
20-day SMA
Buy
Level
$38.30
Relative Strength Index (RSI14)
Buy
Level
62.53
ADX Line
Buy
Level
29.02
Williams %R
Neutral
Level
-22.7431
50-day SMA
Buy
Level
$37.44
MACD (12, 26)
Buy
Level
9.11
25-day Aroon Oscillator
Buy
Level
36
On Balance Volume
Neutral
Level
8.1M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.6525)
Buy
CA Score
(Annual)
Level (1.3316)
Buy
Beneish M-Score
(Annual)
Level (-2.8887)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-2.9947)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
CareTrust REIT, Inc. engages in the ownership, acquisition, and leasing of healthcare-related properties. It offers independent living, memory care, and assisted, and skilled nursing facilities. The company was founded on October 29, 2013 and is headquartered in Dana Point, CA.
Stock Forecast FAQ
In the current month, CTRE has received 8 Buy ratings 1 Hold ratings, and 0 Sell ratings. The CTRE average analyst price target in the past 3 months is $43.27.
-
Where Will CareTrust REIT, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that CareTrust REIT, Inc. share price will rise to $43.27 per share over the next 12 months.
-
What Do Analysts Say About CareTrust REIT, Inc.?
Analysts are divided on their view about CareTrust REIT, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CareTrust REIT, Inc. is a Sell and believe this share price will drop from its current level to $39.00.
-
What Is CareTrust REIT, Inc.'s Price Target?
The price target for CareTrust REIT, Inc. over the next 1-year time period is forecast to be $43.27 according to 9 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is CTRE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for CareTrust REIT, Inc. is a Buy. 8 of 9 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CTRE?
You can purchase shares of CareTrust REIT, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CareTrust REIT, Inc. shares.
-
What Is The CareTrust REIT, Inc. Share Price Today?
CareTrust REIT, Inc. was last trading at $40.04 per share. This represents the most recent stock quote for CareTrust REIT, Inc.. Yesterday, CareTrust REIT, Inc. closed at $40.05 per share.
-
How To Buy CareTrust REIT, Inc. Stock Online?
In order to purchase CareTrust REIT, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get CTRE Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CTRE
Sector
P/E ratio
25.77x
18.50x
PEG ratio
0.26x
0.05x
P/B ratio
2.21x
0.83x
Price / LTM sales
17.14x
3.22x
Growth Metrics
CTRE
Sector
Revenue growth
55.29%
2.37%
Earnings growth
74.2%
-1.55%
Revenue (5-year growth)
21.73%
3.41%
Earnings forecast
$0.39
$0.13
Profitability
CTRE
Sector
Profitability FY 2025
$374.9M
$147.2M
Return on invested capital
7.45%
1.8%
Return on assets
7.19%
1.68%
Return on equity
9.25%
3.34%
Earnings Date
Last Earnings Date
Feb
12
Next Earnings Date
Apr
30
Estimated Next Earnings Date
May
14
Balance Sheet
CTRE
Sector
Total cash
$198M
$70.8M
Short term investments
--
$12.4M
Total assets
$5.1B
$3.2B
Long term debt
$894.2M
$338.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 21
RingCentral, Inc. [RNG] is up 34.37% over the past day.
Sell
9
FROG alert for Feb 21
JFrog Ltd. [FROG] is down 24.98% over the past day.
Buy
72
SNSE alert for Feb 21
Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
